The Hartford Hospital Cardiac Catheterization Laboratory has established the largest coronary angioplasty program in New England for the treatment of coronary arteries that have been completely occluded for prolonged periods of time – coronary artery chronic total occlusions (CTO). Historically, this subgroup of coronary artery occlusions has been difficult to treat with angiplasty. Recent technological advances in coronary angioplasty have allowed these blockages to be opened with greater efficacy and at low risk.
Under the guidance of program directors, Jeffrey A Hirst M.D. and Daniel B. Fram M.D., 160 patient’s (as of May, 2015) have undergone CTO PCI at HH with an 87% success rate. Traditional national success rates have been in the range of 40-50%. Large registry data has shown that successful CTO PCI can provide significant clinical benefit to patient’s including: Relief of angina and shortness of breath, improved heart muscle function, reduced risk of abnormal heart rhythms and possibly a decrease in mortality from chronic coronary artery disease.